Latest News- High Throughput Screening (HTS) Market: Target identification and validation is expected to lead the Application segment during 2024-2028

The High Throughput Screening (HTS) Market is being driven by Rise in R and D investments

The High Throughput Screening (HTS) Market is expected to grow at a CAGR of 12.12% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 19.9 billion. In the High Throughput Screening (HTS) market, the focus shifts from brand visibility to enhancing product distribution networks, as end-users' specific needs and the complexity of HTS products make marketing and advertising more challenging. Thermo Fisher Scientific acknowledges this challenge and offers additional resources to support clients, including instructional documents, brochures, and educational videos on platforms like YouTube. Key vendors are addressing this awareness gap by promoting the benefits of HTS on their websites. 

Get more information on High Throughput Screening (HTS) Market by requesting a sample report

Which Factors Are Causing a Surge in Market Growth?

The market is segmented based on

• Application
  • Target identification and validation
  • Primary screening
  • Secondary screening
  • Toxicology assessment
  • Stem cell research
  • Biochemical Screening
  • Drug Discovery
  • Life Sciences Research
  • Chemical Biology Programs
  • Secondary screening
• End-user
  • Pharmaceutical and biotechnology companies
  • Academic and research institutes
  • CROs
• Technology
  • Cell-based Assays
  • Lab-on-a-chip Technology (LOC)
  • Label-free Technology
  • Ultra High Throughput Screening
  • 3D Cell Cultures
  • High-Content Screening (HCS)
• Geography
  • North America
    • US
  • Europe
    • Germany
    • France
    • Italy
  • Asia
    • China
    • India
    • Japan
  • Rest of World (ROW)

According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows: 

• Rise in R and D investments
• Increasing prevalence of chronic diseases
• Patent expiration of drugs

However, the market also witnesses some limitations, which are as follows:

• Shortage of trained healthcare professionals
• High cost of drug discovery process and limitations of HTS
• Import duty and distribution issues in developing countries

Benefits of Buying Global High Throughput Screening (HTS) Market Research Report by Technavio

Rich Experience: 20+ years leading global market research, trusted insights across industries.

Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.

Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.

Market Scope in High Throughput Screening (HTS) Market Research Report

Request Free Sample

Find out which segment is leading the market by accessing the free PDF report

Research Analysis Overview

The High Throughput Screening (HTS) market encompasses technologies such as Lab Automation, High-Content Imaging, Image Cytometry, Data Management, Data Visualization, and Workflow Optimization. It includes Assay Validation and Optimization, Compound Management, Compound Registration, and Compound Storage. Screening Data analysis leads to Hit Validation, Structure-Activity Relationship, Lead Identification, and Lead Optimization. Areas of application include Medicinal Chemistry, Chemical Biology, Molecular Biology, Cellular Biology, and various Disease Areas like Infectious Diseases, Cardiovascular Disease, Metabolic Disease, Rare Disease, Drug Resistance, Target Discovery, Biomarker Discovery, Drug Repositioning, Disease Modeling, Cell Line Development, Primary Cell Screening, In Silico Screening, Virtual Screening, Computational Chemistry, Systems Biology, Personalized Medicine, Precision Medicine, Clinical Pharmacology, Clinical Trial Design, and Clinical Trial Management.

Market Research Overview

The High Throughput Screening (HTS) market is a significant segment of the global life sciences tools and services industry. This market encompasses automated screening solutions, high content screening, hit identification, lead optimization, target validation, and compound libraries. According to Technavio, the global life sciences tools and services market, which includes this sector, is valued at USD132.53 billion in 2023 and is projected to expand moderately. This market caters to research and development of various product categories, such as capital equipment, instruments, accessories, and consumables, used for pharmaceuticals and biotechnology, as well as laboratory diagnosis of diseases. Additionally, it covers life sciences-related services, including contract research, contract manufacturing, and contract sales.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/